查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1223485

甲狀腺癌症診斷的全球市場 - 產業趨勢與預測(～2030年)

Global Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
出版日期: | 出版商: Data Bridge Market Research | 英文 419 Pages | 商品交期: 請詢問到貨日

價格

全球甲狀腺癌症診斷的市場規模，2023年～2030年預計以5.7％的年複合成長率大幅度成長。甲狀腺結節和甲狀腺癌症的發生率和盛行率上升，甲狀腺癌症診斷檢驗的產品認證增加，推動市場成長。

本報告提供全球甲狀腺癌症診斷市場相關調查分析，產業趨勢與預測，市場區隔分析，企業簡介等資訊。

目錄

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 主要考察

  • PESTEL分析
  • 波特的五力分析
  • 主要市場企業僱用的成長策略

第5章 流行病學

第6章 全球甲狀腺癌症診斷市場法規結構

  • 美國的法規情境
  • 澳洲的法規情境
  • 日本的法規情境
  • 中國的法規情境

第7章 市場概要

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第8章 全球甲狀腺癌症診斷市場:各產品類型

  • 概要
  • 器具
    • 病理學為基礎的器具
    • 成像器具
    • 切片檢查器具
    • 其他
  • 消耗品，配件
    • 套件
    • 試劑
    • 探針
    • 其他的消耗品

第9章 全球甲狀腺癌症診斷市場:各檢驗類型

  • 概要
  • 影像檢查
    • 電腦斷層掃瞄
    • MRI
    • PET掃瞄
    • 其他
  • 血液檢驗
    • 血液化學檢驗
    • 血球數(CBC)
    • 其他
  • 切片檢查
    • 針切片檢查
    • 支氣管鏡切片檢查
    • 核心切片檢查
    • 其他
  • 其他

第10章 全球甲狀腺癌症診斷市場:各癌症類型

  • 概要
  • 乳頭癌症
  • 濾胞癌症
  • 其他

第11章 全球甲狀腺癌症診斷市場:各階段

  • 概要
  • 階段Ⅰ
  • 階段Ⅱ
  • 階段Ⅲ
  • 階段Ⅳ

第12章 全球甲狀腺癌症診斷市場:各年齡層

  • 概要
  • 30歲～65歲
  • 65歲以上
  • 21歲～29歲
  • 不滿21歲

第13章 全球甲狀腺癌症診斷市場:各終端用戶

  • 概要
  • 醫院
  • 附屬研究所
  • 獨立的診斷研究所
  • 影像診斷中心
  • 癌症研究機關
  • 其他

第14章 全球甲狀腺癌症診斷市場:各流通管道

  • 概要
  • 直接提供
  • 零售

第15章 全球甲狀腺癌症診斷市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 瑞士
    • 土耳其
    • 比利時
    • 荷蘭
    • 其他的歐洲
  • 亞太地區
    • 日本
    • 中國
    • 韓國
    • 印度
    • 泰國
    • 新加坡
    • 印尼
    • 馬來西亞
    • 菲律賓
    • 澳洲
    • 越南
    • 其他的亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他的南美
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 埃及
    • 以色列
    • 其他的中東、非洲

第16章 全球甲狀腺癌症診斷市場:企業形勢

  • 企業佔有率分析:世界
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第17章 SWOT分析

第18章 企業簡介

  • CANON INC.
  • FUJIFILM CORPORATION
  • F. HOFFMANN-LA ROCHE LTD
  • QUEST DIAGNOSTICS INCORPORATED
  • ILLUMINA, INC.
  • ABBOTT
  • BD
  • BEIJING O&D BIOTECH CO., LTD.
  • BIOMERIEUX SA
  • DIASORIN S.P.A.
  • FONAR CORP.
  • GENERAL ELECTRIC
  • HOLOGIC INC.
  • KONINKLIJKE PHILIPS N.V.
  • MERCK KGAA.

The global thyroid cancer diagnostics market is projected to register a substantial CAGR of 5.7% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Global Thyroid Cancer Diagnostics Market, By Product Type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, Others), Cancer type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group ( 30-65, 65 and above, 21-29, Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, Rest of Middle East and Africa) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the global thyroid cancer diagnostics market are:

Rising incidence and prevalence of thyroid nodules & cancer

Rising thyroid cancer diagnostic tests rise in product approvals

Rise in healthcare expenditure for cancer diagnosis and treatment

Rising awareness towards thyroid cancer

Market Players:

Some of the major players operating in the global thyroid cancer diagnostics market are:

Canon Inc.

FUJIFILM Holdings Corporation

F. Hoffmann-La Roche Ltd

Quest Diagnostics Incorporated

Illumina

Koninklijke Philips N.V.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

Abbott

General Electric Company

BD

QIAGEN

DIASORIN S.P.A.

Merck KGaA

Hologic

Myriad Genetics Inc.

BIOMERIEUX

FONAR Corp.

Time Medical Holding.

PlexBio.

MinFound Medical Systems Co., Ltd

Medonica Co. LTD

Beijing O&D Biotech Co., Ltd.

SternMed GmbH

TABLE OF CONTENTS

1 INTRODUCTION 47

  • 1.1 OBJECTIVES OF THE STUDY 47
  • 1.2 MARKET DEFINITION 47
  • 1.3 OVERVIEW OF THE GLOBAL THYROID CANCER DIAGNOSTICS MARKET 47
  • 1.4 LIMITATIONS 49
  • 1.5 MARKETS COVERED 49

2 MARKET SEGMENTATION 52

  • 2.1 MARKETS COVERED 52
  • 2.2 GEOGRAPHICAL SCOPE 53
  • 2.3 YEARS CONSIDERED FOR THE STUDY 54
  • 2.4 CURRENCY AND PRICING 54
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 55
  • 2.6 MULTIVARIATE MODELLING 58
  • 2.7 PRODUCT TYPE LIFELINE CURVE 58
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 59
  • 2.9 DBMR MARKET POSITION GRID 60
  • 2.10 MARKET TESTING TYPE COVERAGE GRID 62
  • 2.11 VENDOR SHARE ANALYSIS 63
  • 2.12 SECONDARY SOURCES 64
  • 2.13 ASSUMPTIONS 64

3 EXECUTIVE SUMMARY 65

4 PREMIUM INSIGHTS 68

  • 4.1 PESTEL ANALYSIS 71
  • 4.2 PORTER'S FIVE FORCES 72
  • 4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 73

5 EPIDEMIOLOGY 74

6 REGULATORY FRAMEWORK OF THE GLOBAL THYROID CANCER DIAGNOSTICS MARKET 75

  • 6.1 REGULATORY SCENARIO IN THE U.S. 75
  • 6.2 REGULATORY SCENARIO IN AUSTRALIA 76
  • 6.3 REGULATORY SCENARIO IN JAPAN 76
  • 6.4 REGULATORY SCENARIO IN CHINA 76

7 MARKET OVERVIEW 77

  • 7.1 DRIVERS 79
    • 7.1.1 RISING INCIDENCE AND PREVALENCE OF THYROID NODULES AND CANCER 79
    • 7.1.2 RISING THYROID CANCER DIAGNOSTIC TESTS 79
    • 7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 80
    • 7.1.4 RISING AWARENESS TOWARDS THYROID CANCER 80
  • 7.2 RESTRAINTS 81
    • 7.2.1 HIGH COST OF DIAGNOSTICS PROCEDURE 81
    • 7.2.2 TISSUE DAMAGE DUE TO HIGH RADIATION EXPOSURE FROM IMAGING TESTS 82
  • 7.3 OPPORTUNITIES 82
    • 7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 82
    • 7.3.2 RISING OBESE POPULATION 83
  • 7.4 CHALLENGES 83
    • 7.4.1 STRINGENT REGULATORY FRAMEWORK FOR THE APPROVAL AND COMMERCIALIZATION OF CANCER DIAGNOSTIC PRODUCTS 83
    • 7.4.2 LACK OF SKILLED AND CERTIFIED EXPERTISE 84

8 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 85

  • 8.1 OVERVIEW 86
  • 8.2 INSTRUMENTS 89
    • 8.2.1 PATHOLOGY BASED INSTRUMENTS 90
      • 8.2.1.1 PCR INSTRUMENTS 90
      • 8.2.1.2 SLIDE STAINING SYSTEMS 90
      • 8.2.1.3 TISSUE PROCESSING SYSTEMS 90
      • 8.2.1.4 CELL PROCESSORS 91
      • 8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 91
    • 8.2.2 IMAGING INSTRUMENTS 91
      • 8.2.2.1 ULTRASOUND SYSTEMS 91
      • 8.2.2.2 CT SYSTEMS 91
      • 8.2.2.3 MRI SYSTEMS 91
      • 8.2.2.4 OTHERS 91
    • 8.2.3 BIOPSY INSTRUMENTS 92
      • 8.2.3.1 NEEDLE BIOPSY 92
      • 8.2.3.2 ENDOSCOPIC BIOPSY 92
      • 8.2.3.3 CORE BIOPSY 92
      • 8.2.3.4 OTHERS 92
    • 8.2.4 OTHERS 92
  • 8.3 CONSUMABLES & ACCESSORIES 93
    • 8.3.1 KITS 94
      • 8.3.1.1 PCR KITS 94
      • 8.3.1.2 DNA POLYMERASE KITS 94
      • 8.3.1.3 NUCLEIC ACID ISOLATION KITS 94
      • 8.3.1.4 OTHERS 94
    • 8.3.2 REAGENTS 95
      • 8.3.2.1 ASSAYS 95
      • 8.3.2.2 BUFFERS 95
      • 8.3.2.3 PRIMERS 95
      • 8.3.2.4 OTHERS 95
    • 8.3.3 PROBES 95
    • 8.3.4 OTHER CONSUMABLES 95

9 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE 96

  • 9.1 OVERVIEW 97
  • 9.2 IMAGING TEST 100
    • 9.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 101
    • 9.2.2 MRI 101
    • 9.2.3 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 101
    • 9.2.4 OTHERS 101
  • 9.3 BLOOD TEST 102
    • 9.3.1 BLOOD CHEMISTRY TESTS 103
    • 9.3.2 COMPLETE BLOOD COUNT (CBC) 103
    • 9.3.3 OTHERS 103
  • 9.4 BIOPSY 103
    • 9.4.1 NEEDLE BIOPSY 104
    • 9.4.2 BRONCHOSCOPY BIOPSY 104
    • 9.4.3 CORE BIOPSY 104
    • 9.4.4 OTHERS 104
  • 9.5 OTHERS 105

10 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 106

  • 10.1 OVERVIEW 107
  • 10.2 PAPILLARY CARCINOMA 110
  • 10.3 FOLLICULAR CARCINOMA 111
  • 10.4 OTHERS 112

11 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY STAGES 113

  • 11.1 OVERVIEW 114
  • 11.2 STAGE I 117
  • 11.3 STAGE II 118
  • 11.4 STAGE III 119
  • 11.5 STAGE IV 120

12 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP 121

  • 12.1 OVERVIEW 122
  • 12.2 30-65 125
  • 12.3 65 AND ABOVE 126
  • 12.4 21-29 127
  • 12.5 BELOW 21 128

13 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY END USER 129

  • 13.1 OVERVIEW 130
  • 13.2 HOSPITALS 133
  • 13.3 ASSOCIATED LABS 134
  • 13.4 INDEPENDENT DIAGNOSTIC LABORATORIES 134
  • 13.5 DIAGNOSTIC IMAGING CENTERS 135
  • 13.6 CANCER RESEARCH INSTITUTES 136
  • 13.7 OTHERS 137

14 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 138

  • 14.1 OVERVIEW 139
  • 14.2 DIRECT TENDER 142
  • 14.3 RETAIL SALES 143

15 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY REGION 144

  • 15.1 OVERVIEW 145
  • 15.2 NORTH AMERICA 151
    • 15.2.1 U.S. 161
    • 15.2.2 CANADA 166
    • 15.2.3 MEXICO 171
  • 15.3 EUROPE 176
    • 15.3.1 GERMANY 186
    • 15.3.2 U.K. 191
    • 15.3.3 ITALY 196
    • 15.3.4 FRANCE 201
    • 15.3.5 SPAIN 206
    • 15.3.6 RUSSIA 211
    • 15.3.7 SWITZERLAND 216
    • 15.3.8 TURKEY 221
    • 15.3.9 BELGIUM 226
    • 15.3.10 NETHERLANDS 231
    • 15.3.11 REST OF EUROPE 236
  • 15.4 ASIA-PACIFIC 237
    • 15.4.1 JAPAN 247
    • 15.4.2 CHINA 252
    • 15.4.3 SOUTH KOREA 258
    • 15.4.4 INDIA 263
    • 15.4.5 THAILAND 268
    • 15.4.6 SINGAPORE 273
    • 15.4.7 INDONESIA 278
    • 15.4.8 MALAYSIA 283
    • 15.4.9 PHILIPPINES 288
    • 15.4.10 AUSTRALIA 294
    • 15.4.11 VIETNAM 299
    • 15.4.12 REST OF ASIA-PACIFIC 304
  • 15.5 SOUTH AMERICA 305
    • 15.5.1 BRAZIL 316
    • 15.5.2 ARGENTINA 321
    • 15.5.3 REST OF SOUTH AMERICA 327
  • 15.6 MIDDLE EAST AND AFRICA 328
    • 15.6.1 SAUDI ARABIA 339
    • 15.6.2 U.A.E. 344
    • 15.6.3 SOUTH AFRICA 349
    • 15.6.4 EGYPT 355
    • 15.6.5 ISRAEL 360
    • 15.6.6 REST OF MIDDLE EAST AND AFRICA 365

16 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: COMPANY LANDSCAPE 366

  • 16.1 COMPANY SHARE ANALYSIS: GLOBAL 366
  • 16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 367
  • 16.3 COMPANY SHARE ANALYSIS: EUROPE 368
  • 16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 369

17 SWOT ANALYSIS 370

18 COMPANY PROFILE 371

  • 18.1 CANON INC. 371
    • 18.1.1 COMPANY SNAPSHOT 371
    • 18.1.2 COMPANY SHARE ANALYSIS 371
    • 18.1.3 PRODUCT PORTFOLIO 372
    • 18.1.4 RECENT DEVELOPMENTS 372
  • 18.2 FUJIFILM CORPORATION 373
    • 18.2.1 COMPANY SNAPSHOT 373
    • 18.2.2 REVENUE ANALYSIS 373
    • 18.2.3 COMPANY SHARE ANALYSIS 374
    • 18.2.4 PRODUCT PORTFOLIO 374
    • 18.2.5 RECENT DEVELOPMENT 374
  • 18.3 F. HOFFMANN-LA ROCHE LTD 375
    • 18.3.1 COMPANY SNAPSHOT 375
    • 18.3.2 REVENUE ANALYSIS 375
    • 18.3.3 COMPANY SHARE ANALYSIS 376
    • 18.3.4 PRODUCT PORTFOLIO 376
    • 18.3.5 RECENT DEVELOPMENT 376
  • 18.4 QUEST DIAGNOSTICS INCORPORATED 377
    • 18.4.1 COMPANY SNAPSHOT 377
    • 18.4.2 REVENUE ANALYSIS 377
    • 18.4.3 COMPANY SHARE ANALYSIS 378
    • 18.4.4 PRODUCT PORTFOLIO 378
    • 18.4.5 RECENT DEVELOPMENTS 378
  • 18.5 ILLUMINA, INC. 380
    • 18.5.1 COMPANY SNAPSHOT 380
    • 18.5.2 REVENUE ANALYSIS 380
    • 18.5.3 COMPANY SHARE ANALYSIS 381
    • 18.5.4 PRODUCT PORTFOLIO 381
    • 18.5.5 RECENT DEVELOPMENT 381
  • 18.6 ABBOTT 382
    • 18.6.1 COMPANY SNAPSHOT 382
    • 18.6.2 REVENUE ANALYSIS 382
    • 18.6.3 PRODUCT PORTFOLIO 383
    • 18.6.4 RECENT DEVELOPMENT 383
  • 18.7 BD 384
    • 18.7.1 COMPANY SNAPSHOT 384
    • 18.7.2 REVENUE ANALYSIS 384
    • 18.7.3 PRODUCT PORTFOLIO 385
    • 18.7.4 RECENT DEVELOPMENT 385
  • 18.8 BEIJING O&D BIOTECH CO., LTD. 386
    • 18.8.1 COMPANY SNAPSHOT 386
    • 18.8.2 PRODUCT PORTFOLIO 386
    • 18.8.3 RECENT DEVELOPMENTS 386
  • 18.9 BIOMERIEUX SA 387
    • 18.9.1 COMPANY SNAPSHOT 387
    • 18.9.2 REVENUE ANALYSIS 387
    • 18.9.3 PRODUCT PORTFOLIO 388
    • 18.9.4 RECENT DEVELOPMENTS 388
  • 18.10 DIASORIN S.P.A. 389
    • 18.10.1 COMPANY SNAPSHOT 389
    • 18.10.2 REVENUE ANALYSIS 389
    • 18.10.3 PRODUCT PORTFOLIO 390
    • 18.10.4 RECENT DEVELOPMENT 390
  • 18.11 FONAR CORP. 391
    • 18.11.1 COMPANY SNAPSHOT 391
    • 18.11.2 REVENUE ANALYSIS 391
    • 18.11.3 PRODUCT PORTFOLIO 392
    • 18.11.4 RECENT DEVELOPMENTS 392
  • 18.12 GENERAL ELECTRIC 393
    • 18.12.1 COMPANY SNAPSHOT 393
    • 18.12.2 REVENUE ANALYSIS 393
    • 18.12.3 PRODUCT PORTFOLIO 394
    • 18.12.4 RECENT DEVELOPMENTS 394
  • 18.13 HOLOGIC INC. 395
    • 18.13.1 COMPANY SNAPSHOT 395
    • 18.13.2 REVENUE ANALYSIS 395
    • 18.13.3 PRODUCT PORTFOLIO 396
    • 18.13.4 RECENT DEVELOPMENT 396
  • 18.14 KONINKLIJKE PHILIPS N.V. 397
    • 18.14.1 COMPANY SNAPSHOT 397
    • 18.14.2 REVENUE ANALYSIS 397
    • 18.14.3 PRODUCT PORTFOLIO 398
    • 18.14.4 RECENT DEVELOPMENT 398
  • 18.15 MERCK KGAA. 399
    • 18.15.1 COMPANY SNAPSHOT 399
    • 18.15.2 REVENUE ANALYSIS 399
    • 18.15.3 PRODUCT PORTFOLIO 400
    • 18.15.4 RECENT DEVELOPMENT 400
  • 18.16 MEDONICA CO. LTD 401
    • 18.16.1 COMPANY SNAPSHOT 401
    • 18.16.2 PRODUCT PORTFOLIO 401
    • 18.16.3 RECENT DEVELOPMENT 401
  • 18.17 MINFOUND MEDICAL SYSTEMS CO. LTD 402
    • 18.17.1 COMPANY SNAPSHOT 402
    • 18.17.2 PRODUCT PORTFOLIO 402
    • 18.17.3 RECENT DEVELOPMENTS 403
  • 18.18 MYRIAD GENETICS, INC. 404
    • 18.18.1 COMPANY SNAPSHOT 404
    • 18.18.2 REVENUE ANALYSIS 404
    • 18.18.3 PRODUCT PORTFOLIO 405
    • 18.18.4 RECENT DEVELOPMENTS 405
  • 18.19 PLEXBIO. 406
    • 18.19.1 COMPANY SNAPSHOT 406
    • 18.19.2 PRODUCT PORTFOLIO 406
    • 18.19.3 RECENT DEVELOPMENTS 406
  • 18.20 QIAGEN 407
    • 18.20.1 COMPANY SNAPSHOT 407
    • 18.20.2 REVENUE ANALYSIS 407
    • 18.20.3 PRODUCT PORTFOLIO 408
    • 18.20.4 RECENT DEVELOPMENT 408
  • 18.21 STERNMED GMBH 409
    • 18.21.1 COMPANY SNAPSHOT 409
    • 18.21.2 PRODUCT PORTFOLIO 409
    • 18.21.3 RECENT DEVELOPMENTS 409
  • 18.22 SIEMENS HEALTHCARE GMBH 410
    • 18.22.1 COMPANY SNAPSHOT 410
    • 18.22.2 REVENUE ANALYSIS 410
    • 18.22.3 PRODUCT PORTFOLIO 411
    • 18.22.4 RECENT DEVELOPMENT 411
  • 18.23 TIME MEDICAL HOLDING. 412
    • 18.23.1 COMPANY SNAPSHOT 412
    • 18.23.2 PRODUCT PORTFOLIO 412
    • 18.23.3 RECENT DEVELOPMENT 412
  • 18.24 THERMO FISHER SCIENTIFIC INC. 413
    • 18.24.1 COMPANY SNAPSHOT 413
    • 18.24.2 REVENUE ANALYSIS 413
    • 18.24.3 PRODUCT PORTFOLIO 414
    • 18.24.4 RECENT DEVELOPMENT 414

19 QUESTIONNAIRE 415

20 RELATED REPORTS 419

LIST OF TABLES

  • TABLE 1 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 88
  • TABLE 2 GLOBAL INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 89
  • TABLE 3 GLOBAL INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 90
  • TABLE 4 GLOBAL PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 90
  • TABLE 5 GLOBAL IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 91
  • TABLE 6 GLOBAL BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 92
  • TABLE 7 GLOBAL CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
  • TABLE 8 GLOBAL CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 94
  • TABLE 9 GLOBAL KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 94
  • TABLE 10 GLOBAL REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 95
  • TABLE 11 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 99
  • TABLE 12 GLOBAL IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 100
  • TABLE 13 GLOBAL IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 101
  • TABLE 14 GLOBAL BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
  • TABLE 15 GLOBAL BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 103
  • TABLE 16 GLOBAL BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
  • TABLE 17 GLOBAL BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 104
  • TABLE 18 GLOBAL OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 105
  • TABLE 19 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 109
  • TABLE 20 GLOBAL PAPILLARY CARCINOMA IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
  • TABLE 21 GLOBAL FOLLICULAR CARCINOMA IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
  • TABLE 22 GLOBAL OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
  • TABLE 23 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 116
  • TABLE 24 GLOBAL STAGE I IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 117
  • TABLE 25 GLOBAL STAGE II IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 118
  • TABLE 26 GLOBAL STAGE III IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 119
  • TABLE 27 GLOBAL STAGE IV IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 120
  • TABLE 28 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 124
  • TABLE 29 GLOBAL 30-65 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 125
  • TABLE 30 GLOBAL 65 AND ABOVE IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 126
  • TABLE 31 GLOBAL 21-29 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 127
  • TABLE 32 GLOBAL BELOW 21 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 128
  • TABLE 33 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 132
  • TABLE 34 GLOBAL HOSPITALS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 133
  • TABLE 35 GLOBAL ASSOCIATED LABS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 134
  • TABLE 36 GLOBAL INDEPENDENT DIAGNOSTIC LABORATORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 135
  • TABLE 37 GLOBAL DIAGNOSTIC IMAGING CENTERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 135
  • TABLE 38 GLOBAL CANCER RESEARCH INSTITUTES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 136
  • TABLE 39 GLOBAL OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 137
  • TABLE 40 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 141
  • TABLE 41 GLOBAL DIRECT TENDER IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 142
  • TABLE 42 GLOBAL RETAIL SALES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 143
  • TABLE 43 GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 150
  • TABLE 44 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 156
  • TABLE 45 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 46 NORTH AMERICA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 47 NORTH AMERICA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 48 NORTH AMERICA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 49 NORTH AMERICA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 50 NORTH AMERICA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 51 NORTH AMERICA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 52 NORTH AMERICA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 53 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 54 NORTH AMERICA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 55 NORTH AMERICA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 56 NORTH AMERICA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 57 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 58 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 160
  • TABLE 59 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 160
  • TABLE 60 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 160
  • TABLE 61 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 160
  • TABLE 62 U.S. THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 63 U.S. INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 64 U.S. PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
  • TABLE 65 U.S. IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 66 U.S. BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 67 U.S. CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 68 U.S. KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 69 U.S. REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 70 U.S. THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 71 U.S. IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 72 U.S. BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 73 U.S. BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 74 U.S. THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 75 U.S. THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 164
  • TABLE 76 U.S. THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 165
  • TABLE 77 U.S. THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 165
  • TABLE 78 U.S. THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 165
  • TABLE 79 CANADA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 80 CANADA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 81 CANADA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 82 CANADA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 83 CANADA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 84 CANADA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 85 CANADA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 86 CANADA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 87 CANADA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 88 CANADA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 89 CANADA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 90 CANADA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 91 CANADA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 92 CANADA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 169
  • TABLE 93 CANADA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 170
  • TABLE 94 CANADA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 170
  • TABLE 95 CANADA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 170
  • TABLE 96 MEXICO THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 97 MEXICO INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 98 MEXICO PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 99 MEXICO IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 172
  • TABLE 100 MEXICO BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 172
  • TABLE 101 MEXICO CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 172
  • TABLE 102 MEXICO KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
  • TABLE 103 MEXICO REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
  • TABLE 104 MEXICO THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 173
  • TABLE 105 MEXICO IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 173
  • TABLE 106 MEXICO BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 107 MEXICO BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 108 MEXICO THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 109 MEXICO THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 174
  • TABLE 110 MEXICO THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 175
  • TABLE 111 MEXICO THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 175
  • TABLE 112 MEXICO THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 175
  • TABLE 113 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 181
  • TABLE 114 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 115 EUROPE INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 116 EUROPE PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 117 EUROPE IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 118 EUROPE BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 119 EUROPE CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 120 EUROPE KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 121 EUROPE REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 122 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 123 EUROPE IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 124 EUROPE BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 125 EUROPE BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 126 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 127 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 185
  • TABLE 128 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 185
  • TABLE 129 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 185
  • TABLE 130 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 185
  • TABLE 131 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 186
  • TABLE 132 GERMANY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 186
  • TABLE 133 GERMANY PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 186
  • TABLE 134 GERMANY IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 135 GERMANY BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 136 GERMANY CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 137 GERMANY KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 138 GERMANY REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 139 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 140 GERMANY IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 141 GERMANY BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 142 GERMANY BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 143 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 144 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 190
  • TABLE 145 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 190
  • TABLE 146 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 190
  • TABLE 147 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 190
  • TABLE 148 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 149 U.K. INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 150 U.K. PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 151 U.K. IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 152 U.K. BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 153 U.K. CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 154 U.K. KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 155 U.K. REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 156 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 157 U.K. IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 158 U.K. BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 159 U.K. BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 160 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 161 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 194
  • TABLE 162 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 195
  • TABLE 163 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 195
  • TABLE 164 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 195
  • TABLE 165 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
  • TABLE 166 ITALY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
  • TABLE 167 ITALY PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
  • TABLE 168 ITALY IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 197
  • TABLE 169 ITALY BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 197
  • TABLE 170 ITALY CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 197
  • TABLE 171 ITALY KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 198
  • TABLE 172 ITALY REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 198
  • TABLE 173 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 198
  • TABLE 174 ITALY IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 198
  • TABLE 175 ITALY BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 199
  • TABLE 176 ITALY BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 199
  • TABLE 177 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 199
  • TABLE 178 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 199
  • TABLE 179 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 200
  • TABLE 180 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 200
  • TABLE 181 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 200
  • TABLE 182 FRANCE THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 201
  • TABLE 183 FRANCE INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 201
  • TABLE 184 FRANCE PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 201
  • TABLE 185 FRANCE IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 202
  • TABLE 186 FRANCE BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 202
  • TABLE 187 FRANCE CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 202
  • TABLE 188 FRANCE KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 203
  • TABLE 189 FRANCE REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 203
  • TABLE 190 FRANCE THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 203

LIST OF FIGURES

  • FIGURE 1 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: SEGMENTATION 52
  • FIGURE 2 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 55
  • FIGURE 3 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 56
  • FIGURE 4 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 57
  • FIGURE 5 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 57
  • FIGURE 6 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 59
  • FIGURE 7 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 60
  • FIGURE 8 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: MARKET TESTING TYPE COVERAGE GRID 62
  • FIGURE 9 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 63
  • FIGURE 10 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: SEGMENTATION 67
  • FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THYROID CANCER IS EXPECTED TO DRIVE THE GLOBAL THYROID CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD 68
  • FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL THYROID CANCER DIAGNOSTICS MARKET IN 2023 & 2030 68
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL THYROID CANCER DIAGNOSTICS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD 69
  • FIGURE 14 EUROPE IS THE FASTEST-GROWING MARKET FOR GLOBAL THYROID CANCER DIAGNOSTICS MARKET MANUFACTURERS IN THE FORECAST PERIOD 70
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL THYROID CANCER DIAGNOSTICS MARKET 78
  • FIGURE 16 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 86
  • FIGURE 17 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 87
  • FIGURE 18 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 87
  • FIGURE 19 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 88
  • FIGURE 20 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 97
  • FIGURE 21 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 98
  • FIGURE 22 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 98
  • FIGURE 23 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 99
  • FIGURE 24 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 107
  • FIGURE 25 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 108
  • FIGURE 26 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 108
  • FIGURE 27 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 109
  • FIGURE 28 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, 2022 114
  • FIGURE 29 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION) 115
  • FIGURE 30 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030) 115
  • FIGURE 31 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE 116
  • FIGURE 32 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 122
  • FIGURE 33 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 123
  • FIGURE 34 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 123
  • FIGURE 35 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 124
  • FIGURE 36 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY END USER, 2022 130
  • FIGURE 37 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 131
  • FIGURE 38 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 131
  • FIGURE 39 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 132
  • FIGURE 40 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 139
  • FIGURE 41 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 140
  • FIGURE 42 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 140
  • FIGURE 43 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 141
  • FIGURE 44 FGLOBAL THYROID CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 146
  • FIGURE 45 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY REGION (2022) 148
  • FIGURE 46 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY REGION (2023 & 2030) 148
  • FIGURE 47 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY REGION (2022 & 2030) 149
  • FIGURE 48 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2023-2030) 149
  • FIGURE 49 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 152
  • FIGURE 50 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 154
  • FIGURE 51 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 154
  • FIGURE 52 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 155
  • FIGURE 53 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 155
  • FIGURE 54 EUROPE THYROID CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 177
  • FIGURE 55 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 179
  • FIGURE 56 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 179
  • FIGURE 57 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 180
  • FIGURE 58 EUROPE THYROID CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 180
  • FIGURE 59 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 238
  • FIGURE 60 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 240
  • FIGURE 61 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 240
  • FIGURE 62 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 241
  • FIGURE 63 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 241
  • FIGURE 64 SOUTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 306
  • FIGURE 65 SOUTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 308
  • FIGURE 66 SOUTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 308
  • FIGURE 67 SOUTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 309
  • FIGURE 68 SOUTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 309
  • FIGURE 69 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 329
  • FIGURE 70 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 331
  • FIGURE 71 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 331
  • FIGURE 72 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 332
  • FIGURE 73 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 332
  • FIGURE 74 GLOBAL THYROID CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 366
  • FIGURE 75 NORTH AMERICA THYROID CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 367
  • FIGURE 76 EUROPE THYROID CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 368
  • FIGURE 77 ASIA-PACIFIC THYROID CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 369